- Recent Funding
- Investors
- Morningside
Morningside portfolio
Morningside has 14 portfolio companies on record at Recent Funding, with 3 investments in the last 12 months.
About this page
It led 4 of the 15 rounds it joined. Its most recent investment on record is Sleptay's Series A round in September 2026, alongside Qianju Capital, Shunwei Capital, Decheng Capital and 2 others. By category, its portfolio leans toward Health and bio (10) and Commerce and retail (2). It has co-invested with Sanofi Ventures, Abingworth and SymBiosis, most often Sanofi Ventures (2 rounds).
What Morningside invests in
- Health and bio · 10 · 71%
- Commerce and retail · 2 · 14%
- Education · 2 · 14%
- HR and recruiting · 2 · 14%
- Manufacturing and industrial · 1 · 7%
- Robotics and hardware · 1 · 7%
- Data and analytics · 1 · 7%
- Developer tools and cloud · 1 · 7%
Morningside recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series A | Qianju Capital, Shunwei Capital, Decheng Capital (lead) +2 | ||
| Series B+ · $315M | Fidelity Management & Research Company, Eli Lilly, Abingworth +15 | ||
| Series B+ · $130M | Venrock Healthcare Capital Partners (lead), Wellington Management, TF Capital +6 | ||
| Series B+ · $112M | Abingworth (lead), SymBiosis (lead), Brandon Capital +3 | ||
| Series B+ · $105M | Varia Ventures, Granger Management LLC, NT Investments +6 | ||
| Series B+ · lead | Elikon Venture, Oriza Holdings, OrbiMed +4 | ||
| Series B+ · $12.5M · lead | none named | ||
| Series B+ · $70M | Cowen Group (lead), Bessemer Venture Partners |
How Morningside invests
Morningside portfolio companies
SSleptaySeries A · Sep 2026
AAdvanCell$315MSeries B+ · Jul 2026
AAngitia Bio$130MSeries B+ · Feb 2026
GGeneoscopy$105MSeries B+ · Jan 2025
BBevi$70MSeries B+ · Aug 2022
BBig Health$75MSeries B+ · Jan 2022
DDeepCure$40MSeries A · Nov 2021
EExo Therapeutics$78MSeries B+ · Oct 2021
PPhoreMost$45MSeries B+ · Mar 2021
ZZilliz$43MSeries B+ · Nov 2020
LLeaguebacker
BBetterUpbacker
FF2Gbacker
SSharebitebacker
| Company | Round with Morningside | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series A | undisclosed | Sep 28, 2026 Series A |
Health and bio |
Series B+ · $315M | $439.5M | Jul 15, 2026 Series B+ |
Health and bio |
Series B+ · $130M | $130M | Feb 12, 2026 Series B+ |
Health and bio |
Series B+ · $105M | $216.9M | Jan 8, 2025 Series B+ |
Robotics and hardware |
Series B+ · $70M | $128M | Aug 11, 2022 Series B+ |
Health and bio |
Series B+ · $75M | $129.3M | Jan 19, 2022 Series B+ |
Health and bio |
Series A · $40M · lead | $64M | Apr 11, 2024 Series A |
Health and bio |
Series B+ · $78M | $103M | Oct 5, 2021 Series B+ |
Health and bio |
Series B+ · $45M | $72M | Sep 10, 2024 Series B+ |
Data and analytics |
Series B+ · $43M | $103M | Aug 24, 2022 Series B+ |
Health and bio |
backer | $66M | Jul 24, 2018 Series B+ |
HR and recruiting |
backer | $6M | Oct 22, 2025 Seed |
Health and bio |
backer | $100M | Sep 12, 2024 Series B+ |
Commerce and retail |
backer | $54M | Jun 28, 2022 Series B+ |
Most frequent co-investors
SSanofi Ventures2 shared rounds · last Jul 15, 2026
AAbingworth2 shared rounds · last Jul 15, 2026
SSymBiosis2 shared rounds · last Jul 15, 2026
BBrandon Capital2 shared rounds · last Jul 15, 2026
TTenmile2 shared rounds · last Jul 15, 2026
SSV Health Investors2 shared rounds · last Jul 15, 2026
OOrbiMed2 shared rounds · last Feb 12, 2026
LLegend Capital2 shared rounds · last Feb 12, 2026
YYonghua Capital2 shared rounds · last Feb 12, 2026
LLabCorp2 shared rounds · last Jan 8, 2025
- NNT Investments2 shared rounds · last Jan 8, 2025
LLightchain Capital2 shared rounds · last Jan 8, 2025
Similar investors
- FFidelity Management & Research Company14 companies · 10 deals in 12 mo
Bb2venture14 companies · 7 deals in 12 mo
SSchroders Capital14 companies · 5 deals in 12 mo
BBristol-Myers Squibb14 companies · 4 deals in 12 mo
EExport and Investment Fund14 companies · 4 deals in 12 mo
AAvenir14 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 15 rounds on Recent Funding that name Morningside. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Morningside, which is a subset of its real portfolio. API: /api/v1/investors/morningside (get a free API key). More: the most active VC firms and new venture capital funds.
The week's top funded startups and market insights, in your inbox every Monday.
Unsubscribe anytime · privacy